ALNYLAM PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,677 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 601-625 of 1,000 matching filings.

Per page
25
Current page
25
DEFA14A File 001-36407

DEFA14A

Filing date
08 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36407

DEF 14A

Filing date
21 Mar 2019
Reporting date
25 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-36407

PRER14A

Filing date
18 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36407

PRE 14A

Filing date
11 Mar 2019
Reporting date
25 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SCHEDULE 13G AMENDMENT 3

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SEC SCHEDULE 13G

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
07 Feb 2019
Reporting date
07 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79884

SC 13G/A filing

Filing date
31 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jan 2019
Reporting date
17 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
15 Jan 2019
Reporting date
14 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-217688

424B5

Filing date
15 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-217688

424B5

Filing date
14 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Jan 2019
Reporting date
10 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .